Among non-diabetic patients, those prescribed semaglutide had a lower likelihood of depression compared to those not prescribed the GLP-1 medication
This program is about supporting consistency, not forcing outcomes
Our goal here is practical clarity: to unpack how these tools work, what risks matter most, when they help women, and how to navigate safety, dosing, and the bigger lifestyle context that makes any of this effective
The term has been popularized by direct-to-consumer companies that sell compounded products that are not FDA-approved GLP-1 therapies, at doses that are not based on legitimate, rigorous clinical studies
Williams adds that new studies are uncovering benefits involving other chronic diseases, such as heart disease, Type 1 diabetes and polycystic ovary syndrome (PCOS)